- Home
- RUMBW vs SNN Comparison
RUMBW vs SNN Comparison
Compare RUMBW & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RUMBW | SNN |
|---|---|---|
| Founded | 2013 | 1856 |
| Country | United States | United Kingdom |
| Employees | 135 | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 13.9B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | RUMBW | SNN |
|---|---|---|
| Price | $1.92 | $34.10 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.83 |
| AVG Volume (30 Days) | 39.1K | ★ 599.2K |
| Earning Date | 03-28-2025 | 02-24-2026 |
| Dividend Yield | N/A | ★ 2.17% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | N/A | ★ 0.56 |
| Revenue | $85,651,775.00 | ★ $5,944,000,000.00 |
| Revenue This Year | N/A | $7.71 |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | ★ N/A | $60.38 |
| Revenue Growth | ★ 6.36 | 5.35 |
| 52 Week Low | $4.32 | $23.69 |
| 52 Week High | $4.68 | $38.79 |
Technical Indicators
Market Signals| Indicator | RUMBW | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 61.18 |
| Support Level | $1.80 | $32.42 |
| Resistance Level | $2.11 | $34.20 |
| Average True Range (ATR) | 0.20 | 0.41 |
| MACD | -0.01 | 0.18 |
| Stochastic Oscillator | 35.82 | 95.22 |
Price Performance
Historical ComparisonAbout RUMBW Rumble Inc. Warrant
Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.